MoneyWeek

The huge potential of mRNA technology

What are mRNA vaccines?

onventional vaccines work by training the immune system to recognise and fight viruses or bacteria by introducing an inactivated form of a virus (one that has been rendered harmless) into a patient’s body. However, the biotechnology used in the mRNA vaccines made by Pfizer/ BioNTech and Moderna is fundamentally different. The aim is the same: to train the immune system to recognise and fight off the virus. But these new vaccines accomplish this by using synthetic “messenger RNA” to deliver a snippet of viral code to your

You’re reading a preview, subscribe to read more.

More from MoneyWeek

MoneyWeek2 min read
A Mid Cap Maintaining Momentum
Chemring is a FTSE-250 company with a market value of £943m. Its results for the year to 31 October 2023 were released last December. They revealed the largest order book for over a decade, revenue of £473m (up by 19%), underlying operating profit of
MoneyWeek2 min read
Cash In On Chips With Companies Harnessing The Future Of Technology
The Guinness Global Innovators Fund focuses on firms able to grow profitably and boasting sustainable competitive advantages that lead to high returns on capital both today and in the future. We like companies with high levels of recurring revenues,
MoneyWeek1 min read
Oil Comes Off The Boil
Cooling tensions in the Middle East saw Brent crude ease back below $90 a barrel this week. Still, oil has climbed 16% this year. Traders have returned to focusing on fundamentals, says Erwin Seba for Reuters. “Geopolitical risk premiums” – the extra

Related Books & Audiobooks